Skip to main content

Want a detailed portfolio tracker?

Myriad Genetics (MYGN) Revenue (2009 - 2026)

Myriad Genetics (MYGN) revenue from Sep 30, 2009 to Mar 31, 2026. The TTM Myriad Genetics (MYGN) revenue is $829M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Quarterly Revenue

Myriad Genetics (MYGN) Revenue CAGR table

PeriodCAGR
1 Year TTM-0.28%
3 Years TTM+6.07%
5 Years TTM+38.33%
10 Years TTM+0.92%
All Time TTM+5.35%

Annual Revenue change of Myriad Genetics (MYGN)

YearRevenueChange
2026$200M-75.69%
2025$825M-1.56%
2024$838M+11.21%
2023$753M+11.03%
2022$678M-1.77%
2021$691M+346.70%
2020$155M-20.76%
2019$195M-10.01%
2018$217M+15.38%
2017$188M-4.47%
2016$197M-72.78%
2015$723M-7.16%
2014$778M+26.91%
2013$613M+23.63%
2012$496M+23.36%
2011$402M+10.87%
2010$363M+11.06%
2009$327MN/A

Comparison Myriad Genetics (MYGN) five years revenue CAGR with competitors

Myriad Genetics (MYGN) five years revenue CAGR is 38.33%.